Literature DB >> 17041626

mTOR, translation initiation and cancer.

Y Mamane1, E Petroulakis, O LeBacquer, N Sonenberg.   

Abstract

Control of mRNA translation plays a fundamental role in many aspects of cell metabolism. It constitutes a critical step in the control of gene expression, and consequently cell growth, proliferation and differentiation. Translation is regulated in response to nutrient availability, hormones, mitogenic and growth factor stimulation and is coupled with cell cycle progression and cell growth. Signaling by the PI3K/Akt/mTOR pathway profoundly affects mRNA translation through phosphorylation of downstream targets such as 4E-BP and S6K. Inhibitors of this pathway and thus cap-dependent translation are emerging as promising therapeutic options for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041626     DOI: 10.1038/sj.onc.1209888

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  274 in total

Review 1.  The role of mTOR in memory CD8 T-cell differentiation.

Authors:  Koichi Araki; Ben Youngblood; Rafi Ahmed
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation.

Authors:  Manish R Patel; Ahad A Sadiq; Joe Jay-Dixon; Tanawat Jirakulaporn; Blake A Jacobson; Faris Farassati; Peter B Bitterman; Robert A Kratzke
Journal:  Int J Oncol       Date:  2011-11-04       Impact factor: 5.650

3.  Human cytomegalovirus induces multiple means to combat reactive oxygen species.

Authors:  Carisa Tilton; Amy J Clippinger; Tobi Maguire; James C Alwine
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

4.  mTOR activity under hypoxia.

Authors:  Douangsone D Vadysirisack; Leif W Ellisen
Journal:  Methods Mol Biol       Date:  2012

5.  S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response.

Authors:  Keng Po Lai; Wai Fook Leong; Jenny Fung Ling Chau; Deyong Jia; Li Zeng; Huijuan Liu; Lin He; Aijun Hao; Hongbing Zhang; David Meek; Chakradhar Velagapudi; Samy L Habib; Baojie Li
Journal:  EMBO J       Date:  2010-07-23       Impact factor: 11.598

6.  eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.

Authors:  Luc Furic; Liwei Rong; Ola Larsson; Ismaël Hervé Koumakpayi; Kaori Yoshida; Andrea Brueschke; Emmanuel Petroulakis; Nathaniel Robichaud; Michael Pollak; Louis A Gaboury; Pier Paolo Pandolfi; Fred Saad; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

7.  mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1.

Authors:  Theodoros Kantidakis; Ben A Ramsbottom; Joanna L Birch; Sarah N Dowding; Robert J White
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-11       Impact factor: 11.205

8.  ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).

Authors:  Audrey Carriere; Yves Romeo; Hugo A Acosta-Jaquez; Julie Moreau; Eric Bonneil; Pierre Thibault; Diane C Fingar; Philippe P Roux
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

9.  Differential requirement of mTOR in postmitotic tissues and tumorigenesis.

Authors:  Caterina Nardella; Arkaitz Carracedo; Andrea Alimonti; Robin M Hobbs; John G Clohessy; Zhenbang Chen; Ainara Egia; Alessandro Fornari; Michelangelo Fiorentino; Massimo Loda; Sara C Kozma; George Thomas; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Sci Signal       Date:  2009-01-27       Impact factor: 8.192

10.  Inhibition of Mammalian target of rapamycin by rapamycin causes the regression of carcinogen-induced skin tumor lesions.

Authors:  Panomwat Amornphimoltham; Kantima Leelahavanichkul; Alfredo Molinolo; Vyomesh Patel; J Silvio Gutkind
Journal:  Clin Cancer Res       Date:  2008-12-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.